Serotonin-GABA interactions modulate MDMA-induced mesolimbic dopamine release

Michael G. Bankson, Bryan Yamamoto

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

3,4,-Methylenedioxymethamphetamine (MDMA; 'ecstasy') acts at monoamine nerve terminals to alter the release and re-uptake of dopamine and 5-HT. The present study used microdialysis in awake rats to measure MDMA-induced changes in extracellular GABA in the ventral tegmental area (VTA), simultaneous with measures of extracellular dopamine (DA) in the nucleus accumbens (NAC) shell. (+)-MDMA (0, 2.5, 5 and 10 mg/kg, i.p.) increased GABA efflux in the VTA with a bell-shaped dose-response. This increase was blocked by application of TTX through the VTA probe. MDMA (5 mg/kg) increased 5-HT efflux in VTA by 1037% (p < 0.05). The local perfusion of the 5-HT2B/2C antagonist SB 206553 into the VTA reduced VTA GABA efflux after MDMA from a maximum of 229% to a maximum of 126% of basal values (p < 0.05), while having no effect on basal extracellular GABA concentrations. DA concentrations measured simultaneously in the NAC shell were increased from a maximum of 486% to 1320% (p < 0.05). The selective DA releaser d-amphetamine (AMPH) (4 mg/kg) also increased VTA GABA efflux (180%), did not alter 5-HT and increased NAC DA (875%) (p < 0.05), but the perfusion of SB 206553 into the VTA failed to alter these effects. These results suggest that MDMA-mediated increases in DA within the NAC shell are dampened by increases in VTA GABA subsequent to activation of 5-HT 2B/2C receptors in the VTA.

Original languageEnglish (US)
Pages (from-to)852-859
Number of pages8
JournalJournal of Neurochemistry
Volume91
Issue number4
DOIs
StatePublished - Nov 2004
Externally publishedYes

Fingerprint

N-Methyl-3,4-methylenedioxyamphetamine
Ventral Tegmental Area
gamma-Aminobutyric Acid
Dopamine
Serotonin
Nucleus Accumbens
Dextroamphetamine
Receptor, Serotonin, 5-HT2B
Perfusion
Receptor, Serotonin, 5-HT2C
Serotonin 5-HT2 Receptor Antagonists
Rats
Microdialysis
Chemical activation

Keywords

  • 3,4-methylenedioxymethamphetamine
  • Dopamine
  • Gamma amino butyric acid
  • Nucleus accumbens
  • Serotonin
  • Ventral tegmental area

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

Serotonin-GABA interactions modulate MDMA-induced mesolimbic dopamine release. / Bankson, Michael G.; Yamamoto, Bryan.

In: Journal of Neurochemistry, Vol. 91, No. 4, 11.2004, p. 852-859.

Research output: Contribution to journalArticle

@article{48b34a72b7c744caabae3f58b603e92c,
title = "Serotonin-GABA interactions modulate MDMA-induced mesolimbic dopamine release",
abstract = "3,4,-Methylenedioxymethamphetamine (MDMA; 'ecstasy') acts at monoamine nerve terminals to alter the release and re-uptake of dopamine and 5-HT. The present study used microdialysis in awake rats to measure MDMA-induced changes in extracellular GABA in the ventral tegmental area (VTA), simultaneous with measures of extracellular dopamine (DA) in the nucleus accumbens (NAC) shell. (+)-MDMA (0, 2.5, 5 and 10 mg/kg, i.p.) increased GABA efflux in the VTA with a bell-shaped dose-response. This increase was blocked by application of TTX through the VTA probe. MDMA (5 mg/kg) increased 5-HT efflux in VTA by 1037{\%} (p < 0.05). The local perfusion of the 5-HT2B/2C antagonist SB 206553 into the VTA reduced VTA GABA efflux after MDMA from a maximum of 229{\%} to a maximum of 126{\%} of basal values (p < 0.05), while having no effect on basal extracellular GABA concentrations. DA concentrations measured simultaneously in the NAC shell were increased from a maximum of 486{\%} to 1320{\%} (p < 0.05). The selective DA releaser d-amphetamine (AMPH) (4 mg/kg) also increased VTA GABA efflux (180{\%}), did not alter 5-HT and increased NAC DA (875{\%}) (p < 0.05), but the perfusion of SB 206553 into the VTA failed to alter these effects. These results suggest that MDMA-mediated increases in DA within the NAC shell are dampened by increases in VTA GABA subsequent to activation of 5-HT 2B/2C receptors in the VTA.",
keywords = "3,4-methylenedioxymethamphetamine, Dopamine, Gamma amino butyric acid, Nucleus accumbens, Serotonin, Ventral tegmental area",
author = "Bankson, {Michael G.} and Bryan Yamamoto",
year = "2004",
month = "11",
doi = "10.1111/j.1471-4159.2004.02763.x",
language = "English (US)",
volume = "91",
pages = "852--859",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Serotonin-GABA interactions modulate MDMA-induced mesolimbic dopamine release

AU - Bankson, Michael G.

AU - Yamamoto, Bryan

PY - 2004/11

Y1 - 2004/11

N2 - 3,4,-Methylenedioxymethamphetamine (MDMA; 'ecstasy') acts at monoamine nerve terminals to alter the release and re-uptake of dopamine and 5-HT. The present study used microdialysis in awake rats to measure MDMA-induced changes in extracellular GABA in the ventral tegmental area (VTA), simultaneous with measures of extracellular dopamine (DA) in the nucleus accumbens (NAC) shell. (+)-MDMA (0, 2.5, 5 and 10 mg/kg, i.p.) increased GABA efflux in the VTA with a bell-shaped dose-response. This increase was blocked by application of TTX through the VTA probe. MDMA (5 mg/kg) increased 5-HT efflux in VTA by 1037% (p < 0.05). The local perfusion of the 5-HT2B/2C antagonist SB 206553 into the VTA reduced VTA GABA efflux after MDMA from a maximum of 229% to a maximum of 126% of basal values (p < 0.05), while having no effect on basal extracellular GABA concentrations. DA concentrations measured simultaneously in the NAC shell were increased from a maximum of 486% to 1320% (p < 0.05). The selective DA releaser d-amphetamine (AMPH) (4 mg/kg) also increased VTA GABA efflux (180%), did not alter 5-HT and increased NAC DA (875%) (p < 0.05), but the perfusion of SB 206553 into the VTA failed to alter these effects. These results suggest that MDMA-mediated increases in DA within the NAC shell are dampened by increases in VTA GABA subsequent to activation of 5-HT 2B/2C receptors in the VTA.

AB - 3,4,-Methylenedioxymethamphetamine (MDMA; 'ecstasy') acts at monoamine nerve terminals to alter the release and re-uptake of dopamine and 5-HT. The present study used microdialysis in awake rats to measure MDMA-induced changes in extracellular GABA in the ventral tegmental area (VTA), simultaneous with measures of extracellular dopamine (DA) in the nucleus accumbens (NAC) shell. (+)-MDMA (0, 2.5, 5 and 10 mg/kg, i.p.) increased GABA efflux in the VTA with a bell-shaped dose-response. This increase was blocked by application of TTX through the VTA probe. MDMA (5 mg/kg) increased 5-HT efflux in VTA by 1037% (p < 0.05). The local perfusion of the 5-HT2B/2C antagonist SB 206553 into the VTA reduced VTA GABA efflux after MDMA from a maximum of 229% to a maximum of 126% of basal values (p < 0.05), while having no effect on basal extracellular GABA concentrations. DA concentrations measured simultaneously in the NAC shell were increased from a maximum of 486% to 1320% (p < 0.05). The selective DA releaser d-amphetamine (AMPH) (4 mg/kg) also increased VTA GABA efflux (180%), did not alter 5-HT and increased NAC DA (875%) (p < 0.05), but the perfusion of SB 206553 into the VTA failed to alter these effects. These results suggest that MDMA-mediated increases in DA within the NAC shell are dampened by increases in VTA GABA subsequent to activation of 5-HT 2B/2C receptors in the VTA.

KW - 3,4-methylenedioxymethamphetamine

KW - Dopamine

KW - Gamma amino butyric acid

KW - Nucleus accumbens

KW - Serotonin

KW - Ventral tegmental area

UR - http://www.scopus.com/inward/record.url?scp=8644238146&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=8644238146&partnerID=8YFLogxK

U2 - 10.1111/j.1471-4159.2004.02763.x

DO - 10.1111/j.1471-4159.2004.02763.x

M3 - Article

VL - 91

SP - 852

EP - 859

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

IS - 4

ER -